This study was conducted to establish the extent to which different doses of pituitary porcine growth hormone (ppGH) increase pig growth performance. Pigs were treated daily for 11 wk with 0, 35 or 70 gtg ppGH/kg BW. In addition, these effects were compared with those produced by treating pigs with 0, 35, 70 or 140 #g 9 kg BW -1 9 d -1 of a recombinantly derived analog of porcine growth hormone (rpGH). This analog lacks the first seven amino acids at the NH2 terminus. Growth rate was increased similarly by ppGH and rpGH (the maximal increase was 19%). Feed efficiency was improved by ppGH and rpGH (the maximal response was 25%). This improvement in feed efficiency was associated with a decrease in feed intake (17% with the largest dose of rpGH). Both ppGH and rpGH decreased adipose tissue growth and increased muscle mass. Carcass lipid was decreased by 68% in pigs treated with the largest dose of rpGH. The recombinant pGH analog appeared to be less potent than ppGH in decreasing adipose tissue growth rate. All other parameters measured, however, indicated that rpGH mimicked the biological effects of ppGH (including binding to pig liver membranes and induction of insulin-like growth factor I production). Sensory panel evaluations indicated that neither ppGH nor rpGH affected pork palatability. Larger doses of pGH (> 70 gtg/kg BW) adversely affected pig mobility. This impairment in mobility appears to be due to osteochondrosis. Our findings establish that the rpGH analog is equipotent to ppGH in stimulating growth performance and that pigs can be treated without any significant adverse effects when they are treated with less than 70 gtg of pGH 9 kg BW -1 9 d -1 .
Introduction
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4Pitman-Moore Inc., Terre Haute, IN. Received November 2, 1987 . Accepted March 7, 1988 treating pigs daily with pituitary porcine growth hormone (ppGH) markedly enhances growth rate, improves feed efficiency, decreases adipose tissue growth and increases muscle growth. Although our studies have shown that ppGH alters growth performance and have provided information about the effects of various doses of pGH on response, the studies were conducted for only 30 to 35 d. In addition, there is no evidence that establishes that recombinant porcine growth hormone (rpGH) is equipotent to ppGH in stimulating growth performance of pigs. Because of this we conducted the present study to establish the effects of treating pigs long-term (77 d) with either ppGH or rpGH. Pigs were treated with different doses of the hormones in order to establish a more definitive dose-response relationship than the one reported in our earlier study .
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Because this is the first study reported using ~. a recombinantly derived pGH in a growth trial, several experiments were conducted to deter-~. z.5-mine the relative biological potency of rpGH vs ppGH. These studies were important because the rpGH used is not a perfect construct of .~ 5-ppGH in that it lacks the first seven amino acids ~-at the NH2 terminus of the molecule. To 2.5-compare the biological effects of ppGH and rpGH several experiments were conducted using pigs or pig tissues. We felt that using this homologous system was more relevant than 0-comparing the two proteins in a rat bioassay. The bioassays used to compare the two sources of pGH were 1) a specific pGH radioreceptor assay (RRA) using pig liver membranes ; 2) the ability of rpGH and ppGH to increase serum insulin-like growth factor I (IGF-I) concentrations in pigs after 7 d of pGH treatment (70 #g 9 kg BW -1 9 d-l); and 3) an in vitro incubation with pig adipose tissue explants to measure the relative inhibition of insulin action by pGH (which is a specific metabolic effect of pGH; . Finally, a comparison was made of the ability of ppGH and rpGH to bind to antiserum (guinea pig) raised against ppGH (Chung et al., 1985) .
Both ppGH s and rpGH 6 were equipotent in inhibiting binding of [12SI] ppGH to liver microsomes ( Figure 1 ). Serum IGF-I concentration was elevated comparably (data not shown) in pigs treated for 7 d with either ppGH or rpGH (blood samples were taken on d 7 at 6 h postinjection). Both rpGH and ppGH inhibited the ability of insulin to maintain lipogenic capacity in cultured pig adipose tissue ( Figure  2 ). This effect was observed irrespective of the body weight of the pigs when the adipose tissue biopsy was taken. Although physiological concentrations of both pGH sources inhibited insulin action, rpGH was less potent than ppGH when data were pooled over the three weight groups. There also were differen~zes between ppGH and rpGH in their ability to bind to the guinea pig antiserum (the concentration of unlabeled ppGH or rpGH that half-maximally inhibited binding of tabeled ppGH was 1.3 and 2.7 ng/ml, respectively). Thus, the ppGH and rpGH used in the present study differ in their s Lot AFP-9164-C, donated by Pitman-Moore, Inc. 6 Lot 117-043, donated by Pitman-Moore, Inc.
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EDso 0---~ ppGH 1.8 ng/ml ~. = rpGH 1.8 ng/ml 0 .3 3 30 I00 pGH (ng/ml) Figure 1 , Comparison of recombinant porcine growth hormone (rpGH) and pituitary porcine growth hormone (ppGH) in a specific pGH radioreceptor assay. The hormone preparations were incubated with pig liver microsomes and tracer ([ ms l]ppGH) for 24 h at 23 ~ C . Microsomes were treated with 4 M MgCI 2 prior to the binding assay to remove endogenously bound pGH. The bar associated with each mean is the SE. N = 6 livers per treatment.
antigenic regions. The observations that rpGH mimicked the biological effects of ppGH in three bioassays, however, led to our hypothesis that ppGH and rpGH should stimulate growth performance in a comparable manner.
To test this hypothesis, seventy-two Yorkshire-Duroc barrows (27 kg BW) were randomly allocated to six treatment groups (control; 35 /~g ppGH 9 kg BW -1 9 d -1;70/agppGH 9 kg BW -1 9 d -1-35//g rpGH 9 kg BW -1 9 d -1 70 /.tg rpGH 9 kg BW -t 9 d -x ; 140/.tg rpGH -kg BW -1 9 d-l). The doses selected were based on the results of a previous short-term (35 d) dose-response study in which the largest dose was 70/~g ppGH/kg BW. We decided that the largest dose in the present study would be increased twofold above that used in the previous study . We did not use a dose of 140/ag ppGH/kg BW because of limited availability of the hormone. Pigs were fed a corn-soybean diet formulated to contain 18% protein . Dietary protein content was increased above NRC (1979) recommendations and lysine was added (.5%) to ensure adequate amino acid availability if pGH treatment decreased feed intake. Because of space availability, pigs were housed two per pen. Pigs were treated daily between 0900 and 1000 with the respective hormone or vehicle for 77 d by i.m. injection in the extensor muscle of the neck. The ppGH and rpGH were dissolved as described by Chung et pGH (ng/ml) Figure 2 . Effects of pituitary porcine growth hormone (ppGH) and recombinant porcine growth hormone (rpGH) on insulin action in cultured pig adipose tissue explants. Adipose tissue biopsies were obtained from six pigs at three different weights. Thin tissue explants were prepared and cultured for 48 h in the presence of 10 ng/ml of insulin, 50 ng/ml of hydrocortisone and various concentrations of pGH Walton et al., ). al. (1985 . Stock solutions were made every 2nd d and stored at 4 ~ C.
To determine the effects of pGH on selected hormone and metabolite concentrations, blood samples were taken by venipuncture 3 h postpGH injection on d 49. Blood samples also were collected at slaughter (d 77). The data presented 7The pigs were killed 24 h after the last pST injection to comply with the requirements established by the Food and Drug Administration.
are for the d-49 samples because of the uniform time between pGH treatment and blood sampling. The results were essentially the same between the two sampling times, with the exception of serum pGH values. The values were much lower on d 77 because the pigs were killed 24 h after the last pGH injection 7. Serum samples were assayed for glucose, blood urea-N, insulin, pGH and IGF-I (Chung et al., 1985; Etherton et al., 1987) .
On d 77, the pigs were transported to The Pennsylvania State University Meats Laboratory. Eight pigs per treatment were killed to obtain carcass information. Immediately after death, selected organs were removed quickly and weighed. The anterior pituitary was weighed and frozen for subsequent measurement of pGH concentration (Chung et al., 1985; ). After the carcasses had chilled for 48 h, standard carcass measurements were made. Carcass composition was determined as described by Etherton et al. (1982) . To determine the effects of pGH on meat quality a sensory evaluation was conducted by a trained sensory panel (methods described in Table 7 footnotes).
As the experiment progressed, it became evident that some of the pigs treated with 70 or 140 /2g pGH/kg BW developed mobility problems. These pigs had difficulty in getting up, limped, and, when standing, were buck-kneed. Because of these observations, blood samples were taken to measure plasma Ca and P concentrations. In addition, when the pigs were killed the tibia and femur were examined from each pig. Samples were taken from the mid-shaft of the bones for measurement of Ca and P. Bones also were sliced longitudinally in wafers 2 to 5 mm thick in order to determine shaft thickness and examine the epiphyseal plate. The epiphyseal growth plates and bones were examined to determine if any difference in gross morphological appearance was apparent (Hill et al., 1984) .
Data were analyzed by the GLM procedure of SAS (1979) . Initial body weight was included in the model as a covariate for analysis of growth performance, muscle and adipose tissue mass data. Other factors in the model were source of hormone, dose of hormone and source x dose interaction. Pen was the experimental unit for feed/gain ratio. For all other analyses, the experimental unit was pig. Multiple regression analysis (Ryan et al., 1976 )was used to generate the least squares regression equations apigs were treated with the noted doses of pGH daily for 77 d by i.m. injection, n = 12 per treatment. b'c'dMeans in a row without a common superscript differ (P < .05).
that describe the relationship between biological response and dose. Means were separated in all analyses using linear contrasts (SAS, 1979) .
Results
Both ppGH and rpGH increased ADG in a similar manner (Table 1, Figure 3a ). At the low dose of pGH, ADG was increased 11%, whereas the maximal increase was 19%. Growth rate was similar among treatment groups until wk 6 of the trial (Figure 4 ). After this, it was evident that growth rates diverged to the extent that pGH-treated pigs grew faster for the remainder of the experiment. Feed efficiency was markedly improved by ppGH and rpGH (Table 2, Figure  3b ). There was little effect of pGH during the first 5 wk of the study (Table 2) . During the remaining 6 wk ppGH and rpGH had a pronounced beneficial effect on feed/gain. During this period, feed efficiency was improved as much as 33%. Over the entire experiment feed efficiency was improved about 25% by the highest dose of pGH. Dose-response analyses (Figure 3b ) indicated that the maximal effect of pGH occurred at approximately 90 /.tg of pGH/kg BW. The improvement in feed efficiency in part was due to a significant decrease in feed intake (Table 3) . Thus, ppGH and rpGH increased growth rate even though feed intake was decreased.
As expected, pGH dramatically decreased fat depth and increased loin-eye area (LEA) in a dose-related manner (Table 4 ). There was a 40 to 50% decrease in fat depth and a 46% increase in LEA. Although backfat depth was decreased, adipose tissue growth in different anatomical regions was differentially affected by pGH. For example, pGH decreased adipose tissue growth (measured as backfat depth) 44% over the last lumbar vertebra, 50% over the last rib and only 22% over the first rib (Table 4) . Furthermore, there was a significant effect of pGH source in the regression analysis for the effects of pGH on carcass lipid and adipose tissue mass (Table  5 , Figure 5a ). Recombinant pGH did not decrease adipose tissue growth to the extent that ppGH did. This difference in potency paralleled the results obtained when the effects of ppGH and rpGH were compared in the adipose tissue bioassay.
Although we did not determine carcass composition of any pigs at the start of the experiment, it is apparent that the larger doses of pGH essentially stopped adipose tissue accretion. This is illustrated by the 68% decrease in carcass lipid observed in pigs treated with 140/ag of rpGH/kg BW (Table 5 ). This decrease in carcass lipid was associated with a concurrent increase in carcass water, protein and muscle (Table 5, Figure 5 ). Both sources of pGH stimulated muscle growth similarly.
Porcine growth hormone not only affected adipose tissue and muscle growth but also stimulated organ growth. Heart, liver and kidney weights were increased by both ppGH and rpGH (Table 6 ). Adrenal weight also was increased on an absolute basis (Table 6 ) and after adjusting for differences in body weight (data not shown).
Nothing has been published about the effects of pGH treatment on meat quality. To establish whether pGH affected meat quality, we performed a sensory evaluation. When pigs were treated for 11 wk with pGH there was a significant decrease in marbling and texture (Table 7) . Firmness and color were not affected. Results from the sensory evaluation panel indicated that there was a modest decrease in tenderness that was greater for ppGH than for rpGH (Table 7) . Juiciness was not affected by pGH treatment, whereas there was some change in flavor. Given the numerical score for the averages, however, it was apparent that the sensory panel did not detect any marked differences between meat from control and pGH-treated pigs (a numerical score of 5 indicated that the sample was neither liked nor disliked).
The serum metabolites and hormones measured responded in a manner that, in general, agreed with our previous studies ( Table  8 ). The only notable exceptions were the extent to which pGH affected serum glucose and insulin. In the present study, both glucose and insulin were elevated considerably-more than in our previous studies. The pituitary content of pGH was decreased in a dose-dependent manner by exogenous ppGH and rpGH (control = 7.6/ag pGH/mg pituitary; 35 ppGH = b'c'dMeans in a row without a common superscript differ (P < .05). b'c'dMeans in the same row without a common superscript difrer (P < .05). bFat depth dorsal to first rib.
CFat depth dorsal to last rib.
dFat depth dorsal to last lumar vertebra.
eLoineye area, f'g'hMeans in a row without a common superscript differ (P < .05). b'c'dMeans in a row without a common superscript differ (P < .05).
3.0; 70 ppGH = 2.1; 35 rpGH = 4.1; 70 rpGH --4.0 and 140 rpGH = 1.6, respectively). The mobility problem noted as the experiment progressed was related to an increased incidence of osteochondrosis (Table 9 ). The predominant lesion observed was characterized by focal deep zones of hypertrophied chondrocytes protruding into the metaphysis. There were no differences in Ca or P concentration of bones or serum among the treatment groups (data not shown).
Discussion
The observations that rpGH stimulated growth performance, improved feed efficiency and altered carcass composition provide the first evidence for pigs that a recombinantly derived growth hormone elicits effects similar to those of the pituitary-derived hormone. However, there were some differences in potency between ppGH and rpGH. For example, rpGH was less potent than ppGH in decreasing adipose tissue mass and percentage carcass lipid. Thus, for this particular biological response, the difference in structure between ppGH and rpGH affected function of the hormone. It is noteworthy that the in vitro bioassay with adipose tissue also indicated that there were potency differences. Based on this, it appears that the in vitro assay that measures the ability of pGH to antagonize insulin action ) is a sensitive method for determining the effects of structural modification of the hormone on biological action. For all other biological effects quantified there were no differences between ppGH and rpGH (e.g., muscle mass, ADG, feed/gain, IGF-I concentration). One explanation for the difference in potency between ppGH and rpGH on adipose tissue and not muscle growth is that the mechanisms by which pGH affects adipose tissue growth differ from those affecting muscle. Whether this is due to a difference in the structure of the pGH receptor or a difference in the cascade of events leading to second messenger production and action are unknown.
Although there is no information available that indicates whether pGH receptors differ among target tissues, there is a precedent for the idea that multiple pGH receptors occur within a specific target tissue. In mouse liver membrane preparations, it has been shown through cross-linking studies that there are three receptor subtypes (Smith and Talamantes, 1987) . Other studies with monoclonal antibodies to human growth hormone (Thomas et al., 1987) and rabbit liver growth hormone receptor (Barnard et al., 1985) also have suggested the presence of multiple receptor types for growth hormone. In particular, Thomas et al. (1987) suggested that the relative b'e'dMeans in a row without a common superscript differ (P < .05). aMarbling, texture, firmness and color scores were determined by John Ziegler, Dept. of Food Science, The Pennsylvania State Univ. There were eight pigs per treatment for carcass quality measurements.
bTenderness, flavor and juiciness were determined by a six-member, trained sensory evaluation panel using a lO-cm line scale anchored at 0 = dislike extremely and at 10 cm = like extremely. Panelists scored the pork chops by making a vertical line on the horizontal scale. One-inch loin chops were cooked in a conventional oven to an internal temperature of 167~ (measured by a temperature probe).
C'dMeans in a row without a common superscript differ (P < .05).
proportions of liver receptors may vary according to the physiological state of the animal and, perhaps, among species. The observation that the dose-response curves differ with respect to the maximally effective dose observed for ADG, feed/gain and carcass composition also argues that the mechanisms by which pGH affects growth and metabolism differ. In part, this difference may be a function of whether the effects are mediated directly by pGH or indirectly by IGF-I (Froesch et al., 1986) .
It is important to recognize that pGH is a hormone that not only stimulates growth (somatogenic effects) but also has marked metabolic effects . The effects of pGH on adipose tissue growth in the pig are direct effects not mediated by IGF-I and appear to be due, in part, to a pGH-dependent decrease in basal lipogenic rate , glucose transport (K. Magri and T. Etherton, unpublished data)and in the ability of insulin to stimulate lipid Blood samples were taken 3 h postinjection, n = 12. The results are similar to those obtained from blood collected at slaughter. The only exception was pGH values, which were much lower because samples were obtained 24 h after the last pGH injection.
bBlood urea-N.
Clnsulin-like growth factor 1. dporcine growth hormone. e'f'g'hMeans in a row without a common superscript differ (P < .05). aRatio presented is the number of cases per the number of pigs in the treatment. Although the values presented indicate incidence, they do not represent the severity of the lesions. Typically, the lesions were larger and more extensive for the two larger pGH doses. Mobility of pigs treated with 35 #g pST 9 kg BW -1 9 d -1 was not affected. The incidence of osteochondrosis was increased significantly (P < .05) by pGH but did not differ between rpGH and ppGH (P < .05). Procedure CATMOD of SAS was used. synthesis and glucose oxidation . It also is likely that the decrease in energy intake contributes to the decrease in lipid synthesis. At this time it is our hypothesis, however, that the changes in adipose tissue metabolism that account for the decrease in adipose tissue growth are more the result of specific metabolic effects induced by pGH rather than strictly a function of a decrease in energy intake. Our rationale for this hypothesis is based on 1) our previous studies in which significant changes in adipose tissue growth occurred without any change in feed intake and 2) the finding that basal rates of fatty acid synthesis and insulin sensitivity of pig adipose tissue are markedly depressed after 7 d of treatment with ppGH or rpGH without any change in feed intake .
The effects that pGH has on muscle growth likely are the result of pGH directly and indirectly via IGF-I. The direct effects of pGH are probably associated with an increase in protein synthesis. Although the effects of growth hormone on protein synthesis are established in rats (Albertsson-Wikland and Isaksson, 1978; Albertsson-Wikland et al., 1979 , 1980 Schwartz, 1982) , there is little information available for domestic livestock. Eisemann et al. (1986) reported that whole-body protein synthesis was higher in heifers treated with bovine growth hormone. In addition to the effects that pGH may have on protein metabolism directly, it appears that IGF-I also affects protein metabolism in intact animals. In fasted rats, IGF-I inhibits protein degradation (Jacob et al., 1987) . In conjunction with the effects that IGF-I may have on protein metabolism, it has been shown to increase satellite cell proliferation in culture (Dodson et al., 1985) .
The finding that the effects of pGH were greater during the last 6 wk of the trial provides the first direct evidence to support the hypothesis that pigs that weigh more than 50 to 60 kg are more responsive to pGH than lighter pigs. From a practical perspective, this indicates that pigs only need to be treated from this weight to market weight. From a scientific perspective, the mechanisms that account for this difference in responsiveness to pGH are unclear. Previously, we had speculated that adipose tissue responsiveness to pGH changed during growth and that this contributed to the change in response to pGH . The fact that the concentration of pGH necessary to half-maximally inhibit insulin action in adipose tissue (Figure 3 ) did not change appreciably as pigs grew, however, argues against this. Alternatively, other metabolic pathways such as lipolysis may be affected differently by pGH as pigs grow; however, there is little information available about the effects of pGH on lipolysis in the pig, or about how tissue sensitivity may change during growth.
The apparent effect of pGH on pig mobility after long-term treatment is interesting. In our previous studies we did not see this. However, those studies were shorter (30 to 35 d) and the pigs were not treated with doses so high as those used in the current study. Previously, Machlin (1972) had reported that some pigs treated with pGH developed arthritic-like symptoms. It is unlikely that this disorder is the result of inadequate dietary Ca or P because dietary content of these minerals exceeded NRC requirements. In addition, the fact that no differences in bone Ca or P were detected further supports the contention that this disorder in not the result of some impairment in bone mineralization. The clinical observations indicate that the osteochondrosis observed in the present study is similar to tibia dyschondroplasia in chickens (Freedman et al., 1985; Hargest et al., 1985a,b) . This is an abnormality of the cartilage growth plate characterized by an unmineralized, nonvascularized plug of cartilage in the metaphysis. It appears that this disorder is the result of a failure of the chondrocytes to hypertrophy completely and undergo the changes necessary for mineralization and vascularization of cartilage to occur (Leach and Gay, 1987) . It is not known whether this is an effect of pGH or is mediated by other physiological adaptations. Evidence to suggest that growth hormone is involved has been reported by Vasilatos-Younken and Leach (1986) , who found that the amplitude of growth hormone secretory spikes was 50% higher in chickens with severe tibial dyschondroplastic lesions in comparison with normal birds.
It is encouraging that the sensory evaluation panel could not discern any appreciable differences between rpGH-and ppGH-treated pork. Based on this, it appears that pGH treatment does not affect pork quality. However, information is needed about the effects that pGH has on meat properties such as water holding capacity and structure that are important during processing of pork.
In summary, a recombinantly derived analog of pGH has been shown to mimic the biological effects of ppGH in pigs treated for 77 d. Before a rpGH-based product for the pork industry becomes a reality, a system for delivering rpGH without daily injection is needed. Our understanding of the mechanisms of pGH action also needs to be increased. This may result in strategies to enhance the biological effects of pGH and resolve the problems that may arise when pigs are treated with large (> 70 /ag/kg BW) doses of pGH. The present results, however, suggest that growth performance can be markedly enhanced without any significant adverse effects when pigs are treated with less than 70 /ag of pGH 9 kg BW -1 9 d -l.
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